See how a mechanistic QSP platform captures disease progression and treatment response to enable better decisions in hematologic drug development.
Modeling complex hematological diseases like MDS and AML requires more than fitting clinical data. It demands a mechanistic understanding of how disease and treatment interact across multiple cell lineages.
What You’ll Learn
Download this poster to explore how mechanistic QSP modeling can:
- Reproduce disease…
